Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Kallikrein 6 ELISA Kit (AC2606)
Cat.#: ASET-1195
Specifications
Description Human Kallikrein 6 ELISA Kit allows for the in vitro quantitative determination of human Kallikrein 6 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1662 Rat TIMP1 ELISA Kit (AC3073) Quantitative inquiry ASET-2476 Human Syndecan 4 ELISA Kit (AC3887) Quantitative inquiry ASET-2480 Human WFS1 ELISA Kit (AC3891) Quantitative inquiry ASET-2159 Human HAAO ELISA Kit (AC3570) Quantitative inquiry ASET-2236 Human SEMA3B ELISA Kit (AC3647) Quantitative inquiry ASET-1647 Mouse Wnt3a ELISA Kit (AC3058) Quantitative inquiry ASET-2030 Human p75 NGF Receptor ELISA Kit (AC3441) Quantitative inquiry ASET-2080 Human GCLM ELISA Kit (AC3491) Quantitative inquiry ASET-2043 Chicken Luteinizing Hormone ELISA Kit (AC3454) Quantitative inquiry ASET-1883 Human 5HT1B Receptor ELISA Kit (AC3294) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket